News - Intercept Pharmaceuticals

Filter

Current filters:

Intercept Pharmaceuticals

Popular Filters

Strong Ph III data on Intercept’s OCA, but shares hit by side effect concerns

Strong Ph III data on Intercept’s OCA, but shares hit by side effect concerns

17-03-2014

USA-based Intercept Pharmaceuticals reported positive Phase III results on its obeticholic acid (OCA)…

Intercept PharmaceuticalsNephrology and Hepatologyobeticholic acidPharmaceuticalResearch

Intercept rockets on positive liver disease drug trial

10-01-2014

Shares of USA-based Intercept Pharmaceuticals tripled to $275.87 by close of trading on January 9, when…

Dainippon Sumitomo PharmaIntercept PharmaceuticalsNephrology and Hepatologyobeticholic acidPharmaceuticalResearch

Intercept Pharma in $163 million deal with Servier for TGR5 program in type 2 diabetes

10-08-2011

New York, USA-based Intercept Pharmaceuticals has entered into a worldwide ex-USA and Japan agreement…

DiabetesIntercept PharmaceuticalsLicensingPharmaceuticalServier

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top